申请人:Novartis AG
公开号:US20170305903A1
公开(公告)日:2017-10-26
The invention relates to compound of the formula I
or a salt thereof, wherein the substituents are as defined in the specification; to its preparation, to its use as medicament and to medicaments comprising it.